ライフサイエンスコーパス: normal phase

1 ransition between a superradiant phase and a normal phase.

2 no noticeable effect on the dynamics in the normal phase.

3 cteristics of the insulating, superfluid and normal phases.

4 amagnetic normal phase, an antiferromagnetic normal phase, a paramagnetic superradiant phase, and an

5 he products were isolated and subjected to a normal-phase amino HPLC for further separation, purifica

6 ur quantum phases, including: a paramagnetic normal phase, an antiferromagnetic normal phase, a param

7 .5%] of 220) of the identified lesions had a normal phase and reduced R2*.

8 The antiferromagnetic normal phase and the antiferromagnetic superradiant phas

9 mu(opt) (mm/s) values of 4.10 and 5.22 under normal-phase and 3.74 and 4.34 under reversed-phase elut

10 er use of heptane-EtOAc-MeOH-H2O mixtures in normal-phase and reverse phase mode, respectively.

11 of AD white matter combining size-exclusion, normal phase, and gas chromatography, immunoassays, and

12 rs in the SCN are sufficient to maintain the normal phase angle of entrainment.

13 igosaccharides, derivatized, and analyzed by normal-phase anion-exchange chromatography.

14 can be retained and quantified under aqueous normal phase (ANP) conditions, using a Diamond Hydride (

15 phic platforms: reversed phase (RP), aqueous normal phase (ANP), and hydrophilic interaction (HILIC)

16 this intermediate liquid to the para-orbital normal phase at high temperature.

17 le size is increased, we observe a return to normal phase behavior.

18 An AHL selective normal-phase chromatographic purification with addition

19 Previous normal-phase chromatographic studies of ethyl acetate ad

20 s was synonymous with participants using the normal phase chromatography method.

21 The method utilizes both ion exchange and normal phase chromatography to generate fractions of sat

22 -inducing factors from M. tuberculosis using normal phase chromatography, as well as the use of purif

23 zed using a novel acid hydrolysis method and normal phase chromatography.

24 lactosylceramide (GalCer) counterparts using normal phase chromatography.

25 LC conditions to separate the tocopherols by normal-phase chromatography and carotenoids by reverse-p

26 sis thaliana glycoproteins were separated by normal-phase chromatography and subsequently identified

27 ounds and a few solvent systems employed for normal-phase chromatography.

28 echanisms of solute retention and elution in normal-phase chromatography.

29 An HPLC method is described using normal phase conditions with an unbonded silica column t

30 online LC preseparation step, operated under normal phase conditions.

31 irconia columns exhibit high stability under normal-phase conditions at relatively high linear veloci

32 mers under reversed-phase, polar organic and normal-phase conditions, demonstrating the versatility o

33 g balance present in the model underlies the normal phase-constant behavior of the swimmeret system.

34 several metabolites that were resolved on a normal-phase cyano HPLC system.

35 f the block could nonetheless maintain their normal phase difference.

36 In this normal phase, full pairing of the minority atoms was obs

37 A normal phase high performance liquid chromatography (HPL

38 Normal phase high performance liquid chromatography was

39 Normal phase high-performance liquid chromatography (HPL

40 esh tissues were homogenized and analyzed by normal phase high-performance liquid chromatography (HPL

41 t PPARgamma1 activity were fractionated with normal phase high-performance liquid chromatography (NP-

42 d with anthranilic acid, and fractionated by normal phase high-performance liquid chromatography (NP-

43 The coupling of normal-phase high-performance liquid chromatography (HPL

44 derivatives that can be separated by silica normal-phase high-performance liquid chromatography (HPL

45 r metabolites in the sera were quantified by normal-phase high-performance liquid chromatography (HPL

46 to separate ceramides and sphingoid bases by normal-phase high-performance liquid chromatography and

47 Normal-phase high-performance liquid chromatography coup

48 Using normal-phase high-performance liquid chromatography tech

49 AC) prior to analysis by either reversed- or normal-phase high-performance liquid chromatography.

50 pids were fractionated into three classes by normal-phase high-performance liquid chromatography.

51 bel oligosaccharides prior to analysis using normal-phase high-performance liquid chromatography.

52 , the method is based on PLOOH separation by normal-phase high-performance thin-layer chromatography,

53 tion that were in very good agreement with a normal phase HPLC oligosaccharide mapping method.

54 Normal phase HPLC was used to measure retinoid levels.

55 d with Endoglycosidases F2 and H followed by normal phase HPLC with fluorescence detection.

56 racts from oxidized LDL were fractionated by normal phase HPLC.

57 c two-phase system and analyzed by isocratic normal-phase HPLC after dissolving the dried sample in t

58 ation of 13(S)-HODE was achieved by use of a normal-phase HPLC and a solvent system containing hexane

59 iety of light intensities were analyzed with normal-phase HPLC and ERG techniques.

60 ) were investigated for PA composition using normal-phase HPLC and reversed-phase UPLC-TQD-MS.

61 ciency of CsA in the positive ion mode under normal-phase HPLC conditions were explored.

62 e that exhibited alpha values up to 23 under normal-phase HPLC conditions.

63 on factors as high as 15 were achieved under normal-phase HPLC conditions.

64 an mixtures using a combination of capillary normal-phase HPLC coupled off-line to matrix-assisted la

65 The central feature is a normal-phase HPLC separation of individual phospholipid

66 Following normal-phase HPLC separation, the isotopomers are silyla

67 Reverse-phase and normal-phase HPLC were used to purify the inactivating c

68 method, with tocol as internal standard, and normal-phase HPLC with fluorescence detection.

69 The synthetic procyanidins are identical by normal-phase HPLC with fractions isolated from cocoa.

70 Final purification is achieved by normal-phase HPLC with wet ethyl acetate as the mobile p

71 ce liquid chromatography (HPLC), reverse- or normal-phase HPLC, and capillary electrophoresis (CE) of

72 try, exoglycosidase sequencing combined with normal-phase HPLC, and two-dimensional HPLC mapping.

73 ion due to sample matrix interference in the normal-phase HPLC-APPI-MS/MS system was monitored by the

74 btain highly efficient stationary phases for normal-phase HPLC.

75 which paralleled the glucose units used for normal-phase HPLC.

76 On-line normal-phase HPLC/mass spectrometry (LC/MS) with electro

77 opropyl solid-phase extraction; and finally, normal phase LC fractionation.

78 im of this work was to develop an untargeted normal phase LC-MS method, starting from a targeted meth

79 data set to the bioassay data obtained from normal-phase LC fractions is proposed.

80 Specifically, a normal-phase LC process enabled the separation of three

81 In this work, we compared APPI and APCI for normal-phase LC/MS chiral analysis of five pharmaceutica

82 went solid phase extraction with analysis by normal phase liquid chromatography (LC) with ion trap ma

83 Normal phase liquid chromatography mass spectrometry (NP

84 activity of the synthetic [10-(3)H]JHs using normal phase liquid chromatography optimized to give nea

85 rified fraction of each vegetable oil, using normal-phase liquid chromatography, is described and the

86 ows >95% recovery of LPA, followed by online normal-phase liquid chromatography-mass spectrometry.

87 time substantially less than other reported normal phase methods.

88 Reverse-phase (RP) and normal-phase (NP) high-performance liquid chromatography

89 Normal-phase (NP) HPLC purification of the metabolite co

90 etection for lipid standards separated using normal-phase (NP)-TLC and NP-HPTLC were established.

91 re obtained using a 50-mm-long column in the normal phase or polar organic mode.

92 rticipants could broadly be categorised into normal phase or reversed-phase high performance liquid c

93 f the traditional methods of reversed-phase, normal-phase, or polar organic mode.

94 ity-but cell position was decoupled from the normal phasing pattern underlying flexion and extension.

95 The oligosaccharide purification uses a normal-phase polyamide resin (DPA-6S) in custom-made pip

96 e mobile-phase modifiers and additives under normal-phase retention mechanism was demonstrated.

97 as speed, practical use of longer columns, a normal-phase retention mechanism, and reduced use of org

98 chromatography) and provides an alternative, normal-phase retention mechanism.

99 A combined 2-step normal phase separation was applied, first for separatio

100 retical plates/meter for glycocholic acid in normal-phase separation) were preserved in the coupling

101 challenges a Fermi liquid description of the normal phase, shedding new light on the nature of the st

102 l (Hydrastis canadensis) root separated on a normal phase silica gel 60 F(254S) plate and peptides fr

103 r-the-counter pain medication separated on a normal-phase silica gel plate.

104 Normal-phase solvent systems were used due to low solubi

105 rformance liquid chromatography method using normal-phase solvents, a silica column, and evaporative

106 to quantify analytes directly from developed normal-phase thin-layer chromatography plates.

107 the signature of a first-order superfluid-to-normal phase transition, and disappears at a tricritical

108 A normal-phase ultraperformance liquid chromatography coup

109 two-step process, unveiling an intermediate normal phase with spontaneously broken time-reversal sym